Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cultured Thymus Tissue Implantation in Complete DiGeorge Syndrome
NCT00576407Phase 2Completed
- Sponsor
- Sumitomo Pharma
- Start
- Oct 1991
- Primary completion
- Apr 2009
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Rethymic in Velocardiofacial syndrome (VCFS), sponsored by Sumitomo Pharma. Started Oct 1991; status: completed.
02
Drugs
Rethymic
03
Conditions
Velocardiofacial syndrome (VCFS)
Beyond the preview
Go deeper on NCT00576407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576407.